dm1 mcc

DM1-MCC (MCC-DM1) is an anticancer drug DM1 with an MCC linker.

MCC-DM1 is a drug-Linker Conjugates for ADC such ad Anti-CD22-MCC-DM1.

DM1-MCC-PEG3-Biotin is an ADC (antibody-drug conjugate) linker conjugate.

Lys-SMCC-DM1 (Lys-Nε-MCC-DM1) is an antibody-drug conjugate (ADC) targeting human epidermal growth factor receptor 2 (HER2). It contains the microtubule polymerization inhibitor DM1 as the active metabolite, which inhibits microtubule polymerization. It is commonly used in breast cancer research.

MCC, a non-cleavable linker utilized in the production of antibody-drug conjugates (ADCs), is exemplified by MCC-DM1 [1].

(Rac)-Lys-SMCC-DM1 ((Rac)-Lys-Nε-MCC-DM1) is the racemic form of Lys-SMCC-DM1, which serves as a linker-payload component capable of inhibiting tubulin polymerization. It is also recognized as the active metabolite of T-DM1 [1].